Chronic Consumption of Artificial Sweetener in Packets or Tablets and Type 2 Diabetes Risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study.

@article{Fagherazzi2017ChronicCO,
  title={Chronic Consumption of Artificial Sweetener in Packets or Tablets and Type 2 Diabetes Risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study.},
  author={Guy Fagherazzi and Gae͏̈lle Gusto and Aur{\'e}lie Affret and Francesca Romana Mancini and Courtney Dow and Beverley Balkau and Francoise Clavel-Chapelon and Fabrice Bonnet and Marie-Christine Boutron-Ruault},
  journal={Annals of nutrition & metabolism},
  year={2017},
  volume={70 1},
  pages={
          51-58
        }
}
BACKGROUND The influence of artificial sweeteners on metabolic diseases is controversial. Artificially sweetened beverages have been associated with an increased risk of type 2 diabetes (T2D) but biases and reverse causation have been suspected to have influenced the observed association. In addition, it has been suggested that investigation into the relationship between the frequency and duration of the consumption of packet or tablet artificial sweeteners and T2D risk is necessary. METHODS… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES